Screening compound: C19H21FN4O2 (T987-2812)

Screening compound: C<sub>19</sub>H<sub>21</sub>FN<sub>4</sub>O<sub>2</sub> (T987-2812)
Screening compound: C<sub>19</sub>H<sub>21</sub>FN<sub>4</sub>O<sub>2</sub> (T987-2812) alternative view

Chemical Structure Depiction of ChemDiv screening compound
C19H21FN4O2 (T987-2812)

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

T987-2812

Molecular Formula

C19H21FN4O2 (C19 H21 FN4 O2)

Compound Name

N-(2-{[(3-fluorophenyl)methyl]carbamoyl}cyclopentyl)-5-methylpyrazine-2-carboxamide

IUPAC name

N-[(1R2S)-2-{[(3-fluorophenyl)methyl]carbamoyl}cyclopentyl]-5-methylpyrazine-2-carboxamide

SMILES

Cc(nc1)cnc1C(N[C@@H](CCC1)[C@@H]1C(NCc1cccc(F)c1)=O)=O

InChI

InChI=1S/C19H21FN4O2/c1-12-9-22-17(11-21-12)19(26)24-16-7-3-6-15(16)18(25)23-10-13-4-2-5-14(20)8-13/h2,4-5,8-9,11,15-16H,3,6-7,10H2,1H3,(H,23,25)(H,24,26)/t15-,16+/m1/s1

InChI Key

VKFSVEJYIUFROV-CVEARBPZSA-N

MDL Number (MFCD)

C19H21FN4O2 (T987-2812) in Drug Discovery

Included in Screening Libraries

Bcl2-PPI Inhibitors Library (12246 compounds)

Ligand-Gated Ion Channels Library (3887 compounds)

PPI Helix Turn 3D-Mimetics Library (71298 compounds)

Protein Arginine Methyltransferases Library (27925 compounds)

Protein-Protein Interaction Library (218420 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Inhibitors of beta-Catenin Signaling (7445 compounds)

MDM2-p53 interaction inhibitors Library (21687 compounds)

MEF2-HDAC (class II) Modulators Library (5147 compounds)

SH2 PTB Focused Library (6188 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Hemic and lymphatic
  • Nervous system
  • Eye
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Metabolic
  • Cancer
  • Cancer
  • Musculoskeletal
  • Female
  • Hemic and lymphatic
  • Cardiovascular
Mechanism of action:
  • PPI modulators
  • PPI modulators
  • Epigenetic
  • PPI modulators
  • PPI modulators
  • PPI modulators
  • Epigenetic
Targets:
  • Ion Channels
  • Others
Structure:
  • Mimetics
  • Cyclic compounds

References: we are preparing a list of scientific research reports with C19H21FN4O2 (T987-2812) chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound C19H21FN4O2 (T987-2812)?
Check Price and Availability of C19H21FN4O2 (T987-2812), then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of C19H21FN4O2 (T987-2812) you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for C19H21FN4O2 (T987-2812)
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for C19H21FN4O2 (T987-2812)
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of C19H21FN4O2 (T987-2812) available by request